867 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Bronchogenic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
3 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
4 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
5 Not yet recruiting A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer
Condition: Lung Cancer in Normal and Malignant Tumors
Intervention: Drug: ALA-induced Fluorescence
6 Not yet recruiting Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas
Conditions: Small Cell Lung Cancer (SCLC);   Neuroendocrine (NE) Tumors;   Large Cell Neuroendocrine (NE) Tumors
Intervention: Drug: Rhenium Re 188-P2045
7 Recruiting Pemetrexed in Advanced Non-Small-Cell Lung Cancer: at Progression vs Maintenance Therapy After Induction Chemotherapy
Condition: Carcinoma, Non-small-cell Lung
Interventions: Drug: maintenance pemetrexed;   Drug: pemetrexed at progression
8 Recruiting Role of SPECT in Radiotherapy of Lung Cancer and Toxicity Evaluation
Conditions: Non-small-cell Lung Cancer;   Radiation Pneumonitis
Intervention: Other: SPECT-based treatment plan
9 Available Afatinib Expanded Access Program
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: afatinib
10 Unknown  Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Tarceva (erlotinib)
11 Unknown  Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC
Conditions: Carcinoma, Non-Small-Cell Lung;   Neoplasm Metastasis
Intervention: Drug: Erlotinib, Temozolomide
12 Recruiting Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis
Condition: EGFR Mutation Positive Non-small Cell Lung Cancer
Intervention: Drug: EGFR TKIs (gefitinib, erlotinib, afatinib, et al)
13 Recruiting Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Conditions: Malignant Pericardial Effusion;   Malignant Pleural Effusion;   Recurrent Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Other: cytology specimen collection procedure;   Procedure: therapeutic procedure;   Drug: targeted therapy;   Other: laboratory biomarker analysis
14 Recruiting Photodynamic Therapy During Surgery in Treating Patients With Non-Small Cell Lung Cancer That Can be Removed by Surgery
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Drug: temoporfin;   Procedure: therapeutic conventional surgery;   Drug: photodynamic therapy;   Other: laboratory biomarker analysis;   Other: pharmacological study
15 Unknown  Preoperative Chemoradiotherapy Versus Chemotherapy Alone in Nonsmall Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases
Condition: Non-small Cell Lung Cancer
Intervention: Radiation: neoadjuvant chemoradiotherapy
16 Recruiting Dose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable Disease
Condition: NSCLC
Interventions: Drug: Icotinib of routine dose;   Drug: Icotinib of high dose
17 Recruiting First Line Gefitinib by FDG-PET Metabolic Response
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Gefitinib
18 Recruiting Oshadi D and Oshadi R in Combination With Docetaxel, as 2nd Line Therapy for Metastatic Non Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Oshadi D and Oshadi R;   Drug: Docetaxel
19 Recruiting Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Subjects Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer Who Are Current or Former Smokers
Condition: Non-squamous Non-small Cell Lung Cancer
Interventions: Drug: Veliparib;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Cisplatin;   Drug: Pemetrexed
20 Unknown  Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer
Condition: Malignant Pleural Effusion
Interventions: Drug: Bevacizumab;   Drug: Cisplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years